Savara, Inc. (SVRA)
5.66
-0.21
(-3.58%)
USD |
NASDAQ |
Apr 10, 16:00
5.665
0.00 (0.00%)
After-Hours: 20:00
Savara EPS Diluted (Quarterly) : -0.1341 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | -0.6903 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.292 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.24M |
| Total Expenses (Quarterly) | 32.24M |
| Enterprise Value | 952.57M |
| Earnings Yield | -9.44% |
| Normalized Earnings Yield | -9.412 |